Piedmont Investment Advisors’s Meridian Bioscience Inc VIVO Stock Holding History

Piedmont Investment Advisors’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-10,717	Closed	-$189K	–	1317
2019 Q1	$189K	Buy	10,717 +641	+6%	+$10.7K	0.01%	1081
2018 Q4	$175K	Buy	+10,076	New	+$172K	0.01%	959
2018 Q3	–	Sell	-9,853	Closed	-$157K	–	2520
2018 Q2	$157K	Buy	+9,853	New	+$147K	0.01%	943
2016 Q1	–	Sell	-98	Closed	-$2.01K	–	421
2015 Q4	$2.01K	Hold	98	–	–	﹤0.01%	330
2015 Q3	$1.68K	Hold	98	–	–	﹤0.01%	353
2015 Q2	$1.83K	Hold	98	–	–	﹤0.01%	356
2015 Q1	$1.87K	Buy	+98	New	+$1.81K	﹤0.01%	271

Other funds holding VIVO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Piedmont Investment Advisors's VIVO Position: Q2 2019 in Review

Piedmont Investment Advisors sold out of Meridian Bioscience Inc (VIVO) in Q2 2019, closing a stake of 10,717 shares — an estimated $189K sold.

Piedmont Investment Advisors first reported a position in VIVO in Q1 2015 and held it in 7 quarters. The position peaked at $189K in Q1 2019. 173 funds tracked by Wall St. Rank hold VIVO as of Q2 2019.

Piedmont Investment Advisors reported no remaining Meridian Bioscience Inc position as of Q2 2019 after selling out during the quarter.
Piedmont Investment Advisors sold 10,717 Meridian Bioscience Inc shares in Q2 2019, an estimated $189K.
Piedmont Investment Advisors first reported a position in Meridian Bioscience Inc in Q1 2015 and held it in 7 quarters.
Piedmont Investment Advisors's Meridian Bioscience Inc position peaked at $189K in Q1 2019.
173 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q2 2019.

Based on Piedmont Investment Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.